Managing Contracts and Invoices

Deal would be biggest acquisition under chief executive Vas NarasimhanView the full article

Chair and six directors to leave as Danish drugmaker grapples with slowing growth and falling share priceView the full article

Danish maker of obesity drugs says that new leadership is neededView the full article

Lowest doses of Wegovy in oral form will start at $149 a month for US users until AprilView the full article

Participants with type 2 diabetes had an average weight loss of 15.7 per cent after 68 weeks on CagriSema View the full article

Outcome is blow to one of Europe’s largest listed companiesView the full article

Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind View the full article

Results are due soon from two studies using semaglutide to treat thousands of people with the diseaseView the full article

The future of the post-1945 security order hangs in the balanceView the full article

It is possible to develop a model with the best intentions, and for that model to be misused later onView the full article

Enforcement resources directed at gangs at the top rather than consumers who flout law View the full article

Halifax data points to impact of easing borrowing costs akthough affordability challenges remain View the full article

Data highlights lack of progress for female advocates in winning prestigious legal workView the full article

US president says other chipmakers will also be allowed to export advanced semiconductorsView the full article

World’s top AI semiconductor maker says export controls have accelerated Chinese rivals’ advancesView the full article

Visit comes after US clamps down on chipmaker’s sales to ChinaView the full article

Fat gross margin gives the chipmaker plenty of firepower to compete on priceView the full article

Every quarter is a new nail-biter for the chipmakerView the full article

US chipmaker considers expanding its presence in the country even as sales are hit by Washington’s export controlsView the full article

US chip giant’s stock propelled by strong sales of AI systems and prospect of access to ChinaView the full article

US chipmaker’s shares rise as CEO hails ‘incredibly strong’ demand for its products View the full article

Group’s earnings are a bellwether for the health of the artificial intelligence sectorView the full article

Results slightly exceed Wall Street expectations View the full article